Subsequent investigation revealed that the COL1A2 gene (p-value: 0.0064), though not ranked among the top 20 frequently occurring genes, emerged as a promising candidate biomarker with potential in distinguishing adenocarcinoma from CIS and adenoma (Supplementary Table S6). This evidence concerns the gene COL1A2 and in situ carcinoma.